全球生物外科市场-市场规模、份额、成长分析：按类型（手术密封剂、黏剂）-产业预测（2023-2030）

Global Biosurgery Market Size, Share, Growth Analysis, By Type(Surgical sealants, adhesives) - Industry Forecast 2023-2030

出版日期: 2023年10月24日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2021年全球生物外科市场规模为138.9亿美元，2022年为145.6亿美元。预计该市场在预测期内（2023-2030 年）将以 6.9% 的年复合成长率扩张，到 2030 年达到 242.1 亿美元。

在手术技术的进步和对微创手术的需求不断增长的推动下，全球生物外科市场正在经历显着的成长和转型。生物外科涉及使用密封剂、止血剂和软组织修復材料等生物製品来改善癒合和手术效果。这一增长是由手术数量的增加、慢性病患病率的增加以及高龄化所推动的。此外，儘管严格的法规要求和产品成本带来了挑战，但个人化医疗的采用和创新生技药品的开拓正在进一步推动市场扩张。总之，全球生物外科市场为公司开发和商业化先进外科解决方案提供了充满希望的机会。

全球生物外科市场因微创外科技术的日益普及而显着提振，利用生物外科产品具有减少创伤、更快恢復和减少疤痕等优点。患者和外科医生对微创手术的偏好不断增加，加上创新生物材料和手术密封剂等技术进步，正在推动市场成长。

全球生物外科市场面临的主要障碍是严格的法规条件和新产品漫长的核准程序。适用于生物外科产品的法规要求进行广泛的测试、临床试验，并遵守安全性和有效性标准，导致严重的延误和开发成本的增加。这种复杂的法规环境可能会阻碍製造商创新和推出新产品，而与法规合规和产品开拓相关的高成本可能会阻止小型企业进入市场并减缓市场扩张，这可能是一个障碍。

该报告研究了全球生物外科市场并提供了市场概述，包括按类型和地区分類的趋势以及参与市场的公司概况。

主要企业简介
- Johnson & Johnson
- Baxter International Inc.
- Medtronic plc
- Integra LifeSciences Holdings Corporation
- B. Braun Melsungen AG
- Stryker Corporation
- Ethicon, Inc.
- Smith &Nephew plc
- Olympus Corporation
- CR Bard, Inc.
- Zimmer Biomet Holdings, Inc.
- BD
- Atrium Medical Corporation
- Maquet Holding BV &Co. KG
- CryoLife, Inc.
- Johnson Matthey
- CSL Limited
- Biotime, Inc.
- Cohera Medical, Inc.
- Sanofi SA

简介目录

Product Code: SQMIG35G2174

Global Biosurgery Market size was valued at USD 13.89 billion in 2021 and is poised to grow from USD 14.56 billion in 2022 to USD 24.21 billion by 2030, growing at a CAGR of 6.9% in the forecast period (2023-2030).

The global biosurgery market is undergoing significant growth and transformation, driven by advancements in surgical techniques and the rising demand for minimally invasive procedures. Biosurgery entails the use of biological products like sealants, hemostatic agents, and soft tissue repair materials to enhance healing and surgical outcomes. This growth is fueled by increasing surgical volumes, a higher prevalence of chronic illnesses, and an aging population. Furthermore, the adoption of personalized medicine and the development of innovative biologics are further boosting market expansion, despite challenges posed by strict regulatory requirements and product costs. In conclusion, the global biosurgery market offers promising opportunities for companies in the development and commercialization of advanced surgical solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the global biosurgery market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The global biosurgery market is segmented by type and region. Based on type, the market can be segmented into surgical sealants, adhesives, hemostatic agents, soft tissue patches, and bone graft substitutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers:

Increasing Demand for Minimally Invasive Surgical Procedures

The global biosurgery market is significantly propelled by the rising popularity of minimally invasive surgical techniques, which leverage biosurgery products for their advantages like reduced trauma, quicker recovery, and minimal scarring. This increasing preference among patients and surgeons for minimally invasive procedures, along with technological advancements like innovative biomaterials and surgical sealants, contributes to the market's growth.

Restraints:

Regulatory Requirements and Lengthy Approval Processes for New Products

A key obstacle confronting the global biosurgery market is the stringent regulatory prerequisites and protracted approval procedures for novel products. The regulations governing biosurgery items necessitate extensive testing, clinical trials, and adherence to safety and effectiveness criteria, resulting in substantial delays and elevated development expenses. This intricate regulatory landscape can impede manufacturers from innovating and launching new products, while the considerable expenses linked to regulatory adherence and product development may obstruct the entry of small and medium-sized enterprises into the market, creating a hurdle to market expansion.

Market Trends:

A notable trend in the global biosurgery market is the increasing adoption of minimally invasive surgical approaches, which present numerous benefits such as smaller incisions, reduced scarring, faster recovery, and fewer postoperative complications compared to traditional open surgeries. Consequently, there is a rising need for biosurgical products tailored for minimally invasive procedures, driven by the growing preference among patients and healthcare providers for less invasive treatments with comparable or superior outcomes. In response to this trend, biosurgery market manufacturers are prioritizing the development of innovative products and techniques to meet the escalating demand and improve patient satisfaction.

Executive Summary
- Market Overview
- Wheel of Fortune
Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
Market Dynamics & Outlook
- Market Dynamics
Drivers
Opportunities
Restraints
Challenges
- Regulatory Landscape
- Porters Analysis
Competitive rivalry
Threat of Substitute Products
Bargaining Power of Buyers
Threat of New Entrants
Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
Political Impact
Economic Impact
Social Impact
Technical Impact
Environmental Impact
Legal Impact
Global Biosurgery Market by Type
- Market Overview
- Surgical sealants
- adhesives
- hemostatic agents
- soft tissue patches
- and bone graft substitutes
Global Biosurgery Market Size by Region
- Market Overview
- North America
USA
Canada
- Europe
Germany
Spain
France
UK
Rest of Europe
- Asia Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
- Latin America
Brazil
Rest of Latin America
- Middle East & Africa (MEA)
GCC Countries
South Africa
Rest of MEA
Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
By Development
By Company
By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
Key Company Profiles
- Johnson & Johnson (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Baxter International Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Medtronic plc (Ireland)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Integra LifeSciences Holdings Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- B. Braun Melsungen AG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Stryker Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Ethicon, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Smith & Nephew plc (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Olympus Corporation (Japan)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- C.R. Bard, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Zimmer Biomet Holdings, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- BD (Becton, Dickinson and Company) (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Atrium Medical Corporation (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Maquet Holding B.V. & Co. KG (Germany)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CryoLife, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Johnson Matthey (United Kingdom)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- CSL Limited (Australia)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Biotime, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Cohera Medical, Inc. (United States)
Company Overview
Business Segment Overview
Financial Updates
Key Developments
- Sanofi S.A. (France)
Company Overview
Business Segment Overview
Financial Updates
Key Developments